SIGLEC1 and neoplasm: A recent paper reported that CD169+ macrophages in primary tumours were associated with worse prognosis, while the CD169+ macrophages present in lymph node metastasis predicted a better prognosis, implying the protective role of CD169+ lymph node macrophages [80].